Recurrent seizures and serotonin syndrome following "2C-I" ingestion.
Journal of medical toxicology : official journal of the American College of Medical Toxicology – June 01, 2013
Source: PubMed
Summary
Despite severe reactions including recurrent seizures and serotonin syndrome from ingesting the designer drug 2C-I, a young man made a full recovery. This case illustrates the acute dangers of emerging synthetic substances. Comprehensive drug testing confirmed 2C-I's presence, providing vital insights into its pharmacologic properties and the serious health risks it poses, while also demonstrating the potential for positive patient outcomes even in critical situations.
Abstract
The phenethylamines, including 2, 5 dimethoxy-4-iodophenethylamine, commonly referred to as 2C-I, have recently emerged as a new class of designer drugs. Cases of toxicity from these drugs are not well described in the literature. This case report describes a 19 year-old male who insufflated 2C-I. Following the ingestion, the patient developed recurrent seizures, and was taken to the emergency department, where he was noted to be hyperadrenergic and had recurrent seizures. The patient was diagnosed with serotonin syndrome and experienced prolonged respiratory failure, although he ultimately made a full recovery. Comprehensive drug testing revealed the presence of 2C-I. The pharmacologic properties of 2C-I are also discussed.